|
⚲
|
| Neurotherapeutics Pharma Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001385386 |
| Sale | 2008-12-22 ($5.8 M Offered, $3.2 M Sold) |
| Fund | |
| Phone | 7734444180 |
| Address | 8420 W Byrn Mawr Avenue Chicago, 60631 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Brian Williams | |
| Phillip Morgan PhD | |
| Karen Boezi | |
| Holli Carlson | |
| Stephen Wanaski PhD | |
| Stephen Collins Md PhD | |
| Heath Lukatch PhD |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
MBX Crossover Capsule I LLC
✚
|
0.0 | |
|
Greenwald Gerald
✚
|
0.0 | |
|
GS U St LLC
✚
|
0.0 | |
|
McBride John P
✚
|
0.0 | |
|
QCode Media, Inc.
✚
|
0.0 | |
|
QI Corp
✚
|
0.0 | |
|
AJA 401 LLC
✚
|
0.0 | |
|
McGuire Brandon B.
✚
|
0.0 | |
|
Ganpaul Tyrone
✚
|
0.0 | |
|
MBX Capsule 3, a Series of Assure Labs 2021, LLC
✚
|
0.0 |